50 investors, 100 start-ups – Actimi takes first place in the Life Science & Health category

With our product “Telemonitoring for heart failure in the outpatient sector”, we enable doctors to bill for the digital remote monitoring of their patients. This will be made possible by an adjustment to the regulations from 2022.

Actimi provides the infrastructure for this, consisting of the patient-side app, dashboard and HL7 FHIR server. The use of artificial intelligence enables individual alarm notifications in the event of a deterioration in the patient’s health values.

With a three-minute pitch and subsequent Q&A session, our CEO Maximilian Weiß was able to convince the expert jury and beat seven other start-ups in our category.

The large number of inquiries from interested investors confirms that we are on the right track with our vision. Many thanks to the LMU Entrepreneurship Center for the organization and the opportunity to participate. We wish all participating start-ups every success for the future.